This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not include a full text component. The abstract by Perera et al, entitled “The surgical oncology clinical trial ...
Triplet maintenance (olaparib, pembrolizumab, and bevacizumab) in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer: A multi-center, single-arm phase II study (OPEB-01).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results